FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

The FDA has a  new regulatory framework for cannabidiol products is required that achieves a compromise between people's needs for access to CBD products and the monitoring institutions need to control dangers. 

There are several safety issues with CBD consumption, particularly with long-term use. The protections and control of hazards associated with CBD products would be provided by a new regulatory framework, which would be advantageous to consumers. Clear labelling, preventing impurities, and setting CBD content limits are a few risk management strategies.

 Studies have revealed the possibility of liver damage, interactions with particular drugs, and potential harm to the male reproductive system.

People could be unknowingly exposed to CBD through meat, milk and eggs from animals fed CBD. CBD also poses risks to animals and people and covered in this regulation.